🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/01/1999 | 42,34 | 43,04 | 41,41 | 42,34 | +2,26% | 3,87% | 96.634 |
| 22/01/1999 | 41,87 | 41,87 | 39,77 | 41,41 | -2,21% | 5,03% | 86.856 |
| 21/01/1999 | 42,34 | 42,81 | 41,41 | 42,34 | +2,26% | 3,32% | 104.756 |
| 20/01/1999 | 40,94 | 42,58 | 40,70 | 41,41 | +1,14% | 4,57% | 65.963 |
| 19/01/1999 | 44,21 | 44,45 | 40,47 | 40,94 | -3,31% | 8,99% | 148.411 |
| 15/01/1999 | 43,04 | 43,51 | 42,11 | 42,34 | -1,63% | 3,26% | 42.292 |
| 14/01/1999 | 45,15 | 45,38 | 42,58 | 43,04 | -3,16% | 6,22% | 61.341 |
| 13/01/1999 | 44,45 | 44,92 | 41,17 | 44,45 | -1,04% | 8,42% | 79.429 |
| 12/01/1999 | 47,72 | 49,13 | 44,92 | 44,92 | -4,48% | 8,82% | 102.592 |
| 11/01/1999 | 45,85 | 47,26 | 45,38 | 47,02 | +3,61% | 4,08% | 109.057 |
| 08/01/1999 | 46,32 | 46,32 | 45,38 | 45,38 | -2,02% | 2,02% | 72.910 |
| 07/01/1999 | 46,09 | 46,32 | 45,38 | 46,32 | +1,54% | 2,03% | 77.558 |
| 06/01/1999 | 45,15 | 47,72 | 44,68 | 45,62 | +1,56% | 6,74% | 125.809 |
| 05/01/1999 | 43,51 | 44,92 | 42,11 | 44,92 | +7,26% | 6,45% | 106.706 |
| 04/01/1999 | 43,98 | 44,92 | 41,64 | 41,87 | -3,76% | 7,45% | 70.585 |
| 31/12/1998 | 41,17 | 43,51 | 40,47 | 43,51 | +2,20% | 7,39% | 55.357 |
| 30/12/1998 | 41,64 | 43,04 | 40,70 | 42,58 | +4,00% | 5,62% | 61.635 |
| 29/12/1998 | 41,41 | 42,11 | 40,24 | 40,94 | -2,23% | 4,52% | 65.456 |
| 28/12/1998 | 40,70 | 42,58 | 39,77 | 41,87 | +6,55% | 6,90% | 93.642 |
| 24/12/1998 | 38,83 | 39,77 | 38,83 | 39,30 | +1,20% | 2,41% | 35.560 |
| 23/12/1998 | 39,30 | 40,70 | 38,37 | 38,83 | -3,49% | 5,95% | 28.854 |
| 22/12/1998 | 38,83 | 40,70 | 37,90 | 40,24 | +2,99% | 7,23% | 32.167 |
| 21/12/1998 | 40,24 | 41,17 | 38,13 | 39,07 | -1,76% | 7,56% | 51.804 |
| 18/12/1998 | 41,64 | 41,64 | 39,07 | 39,77 | -2,86% | 6,18% | 44.537 |
| 17/12/1998 | 42,81 | 42,81 | 39,77 | 40,94 | -3,31% | 7,10% | 31.793 |
| 16/12/1998 | 42,58 | 43,04 | 41,17 | 42,34 | +1,69% | 4,40% | 126.717 |
| 15/12/1998 | 41,64 | 42,11 | 41,17 | 41,64 | +0,00% | 2,25% | 29.762 |
| 14/12/1998 | 43,04 | 43,04 | 41,17 | 41,64 | -4,30% | 4,35% | 16.297 |
| 11/12/1998 | 43,04 | 43,51 | 40,70 | 43,51 | +4,49% | 6,52% | 79.161 |
| 10/12/1998 | 43,51 | 44,45 | 41,64 | 41,64 | -6,32% | 6,45% | 77.852 |